PanGenomic Health, Inc. Class A (TSE:NARA) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
PanGenomic Health, Inc. has announced an anticipated delay in filing its 2023 financial statements, with a new expected filing date set on or before June 28, 2024, due to payment delays to its auditors. The British Columbia Securities Commission has issued a management cease trade order that restricts company executives from trading securities, but does not hinder shareholder trading. The company is following NP 12-203 guidelines and will continue to provide bi-weekly status updates.
For further insights into TSE:NARA stock, check out TipRanks’ Stock Analysis page.
